Impact of Thrombocytopenia on Survival in Patients with Hepatocellular Carcinoma: Updated Meta-Analysis and Systematic Review

被引:1
|
作者
Kraj, Leszek [1 ,2 ]
Chmiel, Paulina [3 ]
Gryziak, Maciej [1 ]
Grabowska-Derlatka, Laretta [4 ]
Szymanski, Lukasz [2 ]
Wysokinska, Ewa [5 ]
机构
[1] Med Univ Warsaw, Univ Clin Ctr, Dept Oncol, PL-02091 Warsaw, Poland
[2] Polish Acad Sci, Inst Genet & Anim Biotechnol, Dept Mol Biol, PL-01447 Magdalenka, Poland
[3] Med Univ Warsaw, Univ Clin Ctr, PL-02091 Warsaw, Poland
[4] Med Univ Warsaw, Univ Clin Ctr, Dept Clin Radiol 2, PL-02091 Warsaw, Poland
[5] Mayo Clin, Div Hematol & Med Oncol, Jacksonville, FL 32224 USA
关键词
hepatocellular carcinoma; HCC; thrombocytopenia; platelets; outcome; tumor features; ENDOTHELIAL GROWTH-FACTOR; FACTOR-RECEPTOR-ALPHA; PLATELET COUNT; RADIOFREQUENCY ABLATION; PROGNOSTIC-FACTOR; POOR-PROGNOSIS; HEPATITIS-B; CANCER; RESECTION; SIZE;
D O I
10.3390/cancers16071293
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary: Currently, hepatocellular carcinoma (HCC) is one of the most prevalent oncological diagnoses worldwide. Despite intensive research into its pathogenesis and clinical course, numerous issues remain unresolved. In the presented meta-analysis and systematic review, we investigate the potential of blood platelet levels in patients with HCC for prognostic assessment. Blood platelets may play a significant role as an easily measurable laboratory parameter in assessing the prognosis of patients with HCC. Background: Platelets (PLT) have a role in the pathogenesis, progression, and prognosis of hepatocellular carcinoma (HCC) and could represent a readily measurable laboratory parameter to enhance the comprehensive evaluation of HCC patients. Methods: The PubMed, Web of Science, and Scopus databases were searched with a focus on survival as well as patient and tumor-specific characteristics in correlation to reported PLT counts. Survival outcomes were analyzed with both common-effect and random-effects models. The hazard ratio (HR) and its 95% confidence interval (CI) from analyzed trials were incorporated. Studies that did not provide survival data but focused on platelet count correlation with HCC characteristics were reviewed. Results: In total, 26 studies, including a total of 9403 patients, met our criteria. The results showed that thrombocytopenia in HCC patients was associated with poor overall survival (common-effect HR = 1.15, 95% CI: 1.06-1.25; random-effect HR = 1.30, 95% CI: 1.05-1.63). Moreover, three studies reveal significant correlations between PLT indices and tumor characteristics such as size, foci number, and etiology of HCC development. Conclusion: Our meta-analysis confirmed that PLT count could act as a prognostic marker in HCC, especially with a PLT count cut off <100 x 10(3)/mm(3). Further prospective studies focusing on the role of PLT in clearly defined subgroups are necessary.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Impact of pathological factors on survival in patients with upper tract urothelial carcinoma: a systematic review and meta-analysis
    Sharma, Gopal
    Yadav, Anuj Kumar
    Pareek, Tarun
    Kaundal, Pawan
    Tyagi, Shantanu
    Devana, Sudheer Kumar
    Singh, Shrawan Kumar
    INTERNATIONAL BRAZ J UROL, 2022, 48 (03): : 406 - 455
  • [42] Locoregional Therapies for Hepatocellular Carcinoma A Systematic Review and Meta-Analysis
    Patel, Krishnan R.
    Menon, Hari
    Patel, Roshal R.
    Huang, Erich P.
    Verma, Vivek
    Escorcia, Freddy E.
    JAMA NETWORK OPEN, 2024, 7 (11) : e2447995
  • [43] Stereotactic body radiotherapy versus radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis
    Wang, Lei
    Ke, Qiao
    Huang, Qizhen
    Shao, Lingdong
    Chen, Juhui
    Wu, Junxin
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2020, 37 (01) : 1313 - 1321
  • [44] Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis
    Laila Lobo
    Danny Yakoub
    Omar Picado
    Caroline Ripat
    Fiorella Pendola
    Rishika Sharma
    Rana ElTawil
    Deukwoo Kwon
    Shree Venkat
    Loraine Portelance
    Raphael Yechieli
    CardioVascular and Interventional Radiology, 2016, 39 : 1580 - 1588
  • [45] Percutaneous thermal ablation for primary hepatocellular carcinoma: A systematic review and meta-analysis
    Chinnaratha, Mohamed A.
    Chuang, Ming-yu Anthony
    Fraser, Robert J. L.
    Woodman, Richard J.
    Wigg, Alan J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (02) : 294 - 301
  • [46] Diabetes Mellitus and Poorer Prognosis in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
    Wang, Yan-Gang
    Wang, Peng
    Wang, Bin
    Fu, Zheng-Ju
    Zhao, Wen-Juan
    Yan, Sheng-Li
    PLOS ONE, 2014, 9 (05):
  • [47] The relationship between aspirin consumption and hepatocellular carcinoma: a systematic review and meta-analysis
    Wang, Shuai
    Zuo, Lijuan
    Lin, Zhaojin
    Yang, Zhiqin
    Chen, Ran
    Xu, Yan
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [48] Association between sarcopenia and prognosis of hepatocellular carcinoma: A systematic review and meta-analysis
    Jiang, Chuan
    Wang, Yanyan
    Fu, Wei
    Zhang, Guozhuan
    Feng, Xiaoshan
    Wang, Xing
    Wang, Fang
    Zhang, Le
    Deng, Yang
    FRONTIERS IN NUTRITION, 2022, 9
  • [49] Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis
    Lobo, Laila
    Yakoub, Danny
    Picado, Omar
    Ripat, Caroline
    Pendola, Fiorella
    Sharma, Rishika
    ElTawil, Rana
    Kwon, Deukwoo
    Venkat, Shree
    Portelance, Loraine
    Yechieli, Raphael
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2016, 39 (11) : 1580 - 1588
  • [50] Prognostic impact of gamma-glutamyl transpeptidase to platelets ratio on hepatocellular carcinoma patients who have undergone surgery: a meta-analysis and systematic review
    Zhang, Yang
    Jin, Fangfang
    Wu, Yuan
    Wang, Bingyu
    Xie, Jingri
    Li, Yu
    Pan, Yujia
    Liu, Zhaolan
    Shen, Wenjuan
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 35 (08) : 803 - 811